Metasphere Labs Announces Second Amended and Restated LIFE Offering Document

Executive Summary

• Metasphere Labs filed a Second Amended Offering Document authorizing the issuance of up to 5,000,000 units at $0.09 each, targeting minimum gross proceeds of $450,000.
• The company expects approximately $240,960 in net available funds after accounting for an existing working‑capital deficit of $(209,040) as of October 31, 2025.
• Proceeds (if the minimum is met) will be allocated to mandatory corporate/regulatory expenses ($155k), platform development ($45k), digital‑asset initiatives ($20k), sales & marketing ($15k), and unallocated working capital ($215k).

Key Details

• Offering Size: Minimum and maximum of 5,000,000 units at $0.09 per unit.
• Minimum Gross Proceeds: $450,000 (the offering will not close unless this amount is raised).
• Maximum Gross Proceeds: $450,000 (same as minimum; the range reflects a fixed raise target).
• Net Available Funds Post‑Deficit: Approximately $240,960 after deducting the working‑capital deficit of $(209,040) recorded on 31 Oct 2025.
• Use of Proceeds (assuming minimum is met):
• Mandatory corporate and regulatory expenses – $155,000
• Further platform development – $45,000
• Digital asset initiatives – $20,000
• Sales and marketing – $15,000
• Unallocated working capital – $215,000
• Closing Date: Expected on or about 1 December 2025 (subject to meeting the minimum raise).
• Subscription Refund Provision: If the $450,000 minimum is not reached, all subscription funds will be returned without interest or deduction.
• Regulatory Disclosure: Units are not and will not be registered under U.S. securities laws; offering limited to non‑U.S. persons unless an exemption applies.

Notable Quotes

(No direct quotes were provided in the release.)